Summary of Research: Dupilumab for Chronic Obstructive Pulmonary Disease with Type 2 Inflammation: A Pooled Analysis of Two Phase 3, Randomised, Double-Blind, Placebo-Controlled Trials.

Saved in:

Bibliographic Details
Title:	Summary of Research: Dupilumab for Chronic Obstructive Pulmonary Disease with Type 2 Inflammation: A Pooled Analysis of Two Phase 3, Randomised, Double-Blind, Placebo-Controlled Trials.
Authors:	Bhatt, Surya P.¹ (AUTHOR) sbhatt@uabmc.edu, Rabe, Klaus F.² (AUTHOR), Hanania, Nicola A.³ (AUTHOR), Vogelmeier, Claus F.⁴ (AUTHOR), Bafadhel, Mona⁵ (AUTHOR), Christenson, Stephanie A.⁶ (AUTHOR), Papi, Alberto⁷ (AUTHOR), Singh, Dave⁸ (AUTHOR), Walsh, Linda⁹ (AUTHOR), Winders, Tonya¹⁰ (AUTHOR), Bansal, Ashish¹¹ (AUTHOR), Robinson, Lacey B.¹² (AUTHOR)
Source:	Pulmonary Therapy. Jun2026, p1-4. 4p.
Database:	Academic Search Ultimate

Description
ISSN:	23641746
DOI:	10.1007/s41030-026-00361-2